
Valganciclovir hydrochloride
CAS No. 175865-59-5
Valganciclovir hydrochloride ( Ro 107-9070/194 | Valcyte )
产品货号. M12657 CAS No. 175865-59-5
缬更昔洛韦(盐酸盐)是更昔洛韦的L-缬氨酰酯,实际上是更昔洛韦的前药。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
10MG | ¥308 | 有现货 |
![]() ![]() |
25MG | ¥494 | 有现货 |
![]() ![]() |
50MG | ¥721 | 有现货 |
![]() ![]() |
100MG | ¥1126 | 有现货 |
![]() ![]() |
200MG | ¥1604 | 有现货 |
![]() ![]() |
500MG | ¥2811 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Valganciclovir hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述缬更昔洛韦(盐酸盐)是更昔洛韦的L-缬氨酰酯,实际上是更昔洛韦的前药。
-
产品描述Valganciclovir (hydrochloride), the L-valyl ester of ganciclovir, is actually a prodrug for ganciclovir. Valganciclovir is an antiviral medication used to treat cytomegalovirus infections.
-
体外实验Cell Viability Assay Cell Line:A549 cells Concentration:500 μM Incubation Time:5 days, 7days Result:Showed EC50 values ranged from 120.5 μM (Ad4) to 244.4 μM (Ad6).Showed IC50 values was calculated to be 11.74 mM at 7 days post-infection.
-
体内实验Animal Model:Immunosuppressed hamstersDosage:200 mg/kg Administration:Oral gavage (p.o.)Result:Resulted in significantly smaller magnitude of weight loss for all groups.Reduced the liver pathology.
-
同义词Ro 107-9070/194 | Valcyte
-
通路Others
-
靶点Other Targets
-
受体CMV
-
研究领域Infection
-
适应症——
化学信息
-
CAS Number175865-59-5
-
分子量390.82
-
分子式C14H23ClN6O5
-
纯度>98% (HPLC)
-
溶解度Water: 78 mg/mL (199.58 mM); DMSO: 78 mg/mL (199.58 mM)
-
SMILESCC(C)[C@H](N)C(OCC(OCN1C=NC2=C1NC(N)=NC2=O)CO)=O.[H]Cl
-
化学全称[2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate hydrochloride
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Sugawara M, et al. J Pharm Sci, 2000, 89(6), 781-789.
产品手册




关联产品
-
Padsevonil
Padsevonil (UCB-0942、UCB0942) 是一种潜在的抗癫痫药,可作为突触前和突触后抑制剂。
-
IRL-1620 TFA (142569...
IRL-1620 (TFA) is a potent selective endothelin receptor B (ETB) agonist with a Ki value of 16pm.
-
2,3-dihydroxy-3-meth...
2,3-二羟基-3-甲基丁酸是一种化合物。